NTRA

NASDAQ · Biotechnology

Natera Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$322.10

+56.72 (+21.37%)

As of Aug 8, 9:37 PM ET ·

Day Range $306.38 — $323.01

52W Range $135.75 — $288.04

Performance

1D —

1W —

1M —

3M —

6M +52.19%

1Y +105.11%

YTD +40.75%

Open$320.90

Previous Close$265.38

Day High$323.01

Day Low$306.38

52W High$288.04

52W Low$135.75

Volume—

Avg Volume1.19M

Market Cap45.33B

P/E Ratio—

EPS$-1.64

SectorBiotechnology

Technical Indicators

Full analysis →

SMA 50 $229.31 Above

SMA 200 $186.42 Above

RSI (14) 38.6 Neutral

Trend Golden Cross Bullish

Analyst Ratings

Strong Buy

30 analysts

26 Buy 4 Hold 0 Sell

Price Target -55.6% upside

Current
$322.10

Target
$142.91

$88.14 $142.91 avg $188.78

Key Financials

	FY 2026	FY 2025	FY 2024
Revenue	2.37B	1.68B	5.13B
Net Income	-214,247,722	-136,618,215	875.75M
Profit Margin	-9.0%	-8.6%	17.1%
EBITDA	-317,213,277	-213,513,258	1.33B
Free Cash Flow	—	—	778.23M
Rev Growth	+41.1%	+41.1%	+14.5%
Debt/Equity	0.05	0.05	1.21

Biotechnology Peers

Symbol	Name	Price	Change	P/E	Mkt Cap
ABBV	Abbvie Inc	$246.04	+0.89%	118.6	430.95B
AMGN	Amgen Inc	$410.95	+1.51%	25.1	219.39B
GILD	Gilead Sciences Inc	$133.21	+1.80%	—	165.85B
VRTX	Vertex Pharmaceuticals Inc	$496.07	+2.49%	28.3	124.51B
REGN	Regeneron Pharmaceuticals	$784.36	+1.59%	18.4	79.53B
ALNY	Alnylam Pharmaceuticals Inc	$219.20	+1.43%	35.2	28.41B